Clinical Trials on Advanced NSCLC in Netherlands
Total 275 results
-
Maastricht Radiation OncologyAcademisch Ziekenhuis MaastrichtTerminatedNSCLC | Lung Cancer | SCLCNetherlands
-
The Netherlands Cancer InstituteEnrolling by invitation
-
Radboud University Medical CenterPfizer; ImaginAb, Inc.; University Hospital TuebingenNot yet recruitingNSCLCGermany, Netherlands
-
The Netherlands Cancer InstituteAstraZenecaUnknown
-
Radboud University Medical CenterDutch Society of Physicians for Pulmonology and TuberculosisRecruiting
-
Maastricht Radiation OncologyUniversity of Pennsylvania; University of Wisconsin, MadisonCompleted
-
The Netherlands Cancer InstituteAstraZenecaCompleted
-
The Netherlands Cancer InstituteCompleted
-
Amsterdam UMC, location VUmcCompletedColorectum Advanced Malignancies | Breast Advanced Malignancies | Prostate Advanced MalignanciesNetherlands
-
Radboud University Medical CenterCompletedNSCLC | Locally Advanced Non-Small Cell Lung CancerNetherlands
-
University Hospital, EssenRecruitingNSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIABelgium, Germany, Netherlands
-
The Netherlands Cancer InstituteBristol-Myers SquibbTerminated
-
Novartis PharmaceuticalsCompletedAdvanced Solid MalignanciesNetherlands
-
Academisch Medisch Centrum - Universiteit van Amsterdam...UnknownAdvanced MalignanciesNetherlands
-
AstraZenecaCompleted
-
The Netherlands Cancer InstituteErasmus Medical Center; Amsterdam University Medical Centres (AUMC)Active, not recruitingCRC | Advanced NeoplasiaNetherlands
-
Eisai Inc.Completed
-
Amsterdam UMC, location VUmcCompletedCancer | Advanced Solid TumorsNetherlands
-
Novartis PharmaceuticalsRecruitingAdvanced EGFRmutant NonSmallSellLungCancer (NSCLC),KRAS G12-mutant NSCLC,Esophageal SquamousCellCancer (SCC),Head/Neck SCC,MelanomaSpain, Japan, Korea, Republic of, Taiwan, Netherlands, United States, Italy, Canada, Singapore
-
Radboud University Medical CenterCATO-SMSRecruitingAdvanced Solid TumorNetherlands
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyRecruitingAdvanced Solid TumorNetherlands
-
Maastricht Radiation OncologyAcademisch Ziekenhuis MaastrichtTerminated
-
Clovis Oncology, Inc.CompletedAdvanced Solid TumorNetherlands
-
University Medical Center GroningenActive, not recruiting
-
Amsterdam UMC, location VUmcTerminatedAdvanced or Metastatic Solid MalignancyNetherlands
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruiting
-
Radboud University Medical CenterBayerCompletedAdvanced Solid Tumor | Refractory to Standard TherapiesNetherlands
-
Maastricht Radiation OncologyAstraZeneca; Dutch Society of Physicians for Pulmonology and Tuberculosis; Erasmus... and other collaboratorsRecruiting
-
Maastricht Radiation OncologyKarolinska Institutet; KU Leuven; Maastricht University Medical Center; Catholic... and other collaboratorsWithdrawnNSCLC Stage IV | Limited Metastatic DiseaseNetherlands
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Maastricht Radiation OncologyUniversity Medical Center Groningen; Maastricht University Medical Center; Amsterdam... and other collaboratorsCompleted
-
Debiopharm International SARecruitingAdvanced Solid TumorsNetherlands, Spain
-
Netherlands Institute for Innovative Ocular SurgeryAmnitrans Eyebank RotterdamCompletedAdvanced KeratoconusNetherlands
-
University Medical Center GroningenRecruitingEsophageal Cancer | NSCLC | Radiotherapy Side Effect | Malignant LymphomaNetherlands
-
Eisai Inc.Completed
-
Kling Biotherapeutics B.V.RecruitingAdvanced Solid Tumor MalignancyBelgium, Netherlands
-
Erasmus Medical CenterAlbert Schweitzer Hospital; Maasstad Hospital; Ikazia Hospital, Rotterdam; IJss... and other collaboratorsRecruitingOncology | Implementation | Advance Care PlanningNetherlands
-
Radboud University Medical CenterTerminated
-
Millennium Pharmaceuticals, Inc.Completed
-
Amsterdam UMC, location VUmcUnknownNSCLC | EGFR-mutation | HER2-expressionNetherlands
-
Crescendo Biologics Ltd.University Medical Center GroningenActive, not recruitingAdvanced and/or Metastatic Solid TumoursNetherlands
-
AstraZenecaCompletedNSCLCSweden, Bulgaria, Mexico, Russian Federation, Turkey, United Kingdom, Philippines, Malaysia, Germany, Hungary, Latvia, Lithuania, Poland, Romania, Netherlands, Norway, Argentina, Australia, Canada, Slovakia, Greece, Taiwan, Thailand, ... and more
-
Bristol-Myers SquibbTerminatedAdvanced Solid TumorsUnited States, Netherlands
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumor MalignancyNetherlands, France, Spain
-
AstraZenecaCompletedSafety and Tolerability, | Advanced Solid Malignancy, | Pharmacokinetics, Pharmacodynamics, | Tumour Response,United Kingdom, Netherlands
-
Molecular Partners AGTerminatedAdvanced Malignant Solid TumorNetherlands, France
-
AstraZenecaCompletedHepatic Impairment | Advanced CancerNetherlands, Denmark